NCT00343681View on ClinicalTrials.gov

A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
InfluenzaOrthomyxoviridae Infections
Interventions
BIOLOGICAL

Inactivated influenza vaccine (split virion)

0.5 mL, Intramuscular

Trial Locations (2)

Unknown

Allschwil

Edinburgh

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00343681 - A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine | Biotech Hunter | Biotech Hunter